Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAIN-THROX: Methoxyflurane vs Standard Care for Non-Traumatic Pain in the Emergency Department
2025-525001-21-00Phase 3Authorised
- Sponsor
- CHRU Tours
- Start
- Jun 2026
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of methoxyflurane in pain (2 arms), sponsored by CHRU Tours. Primary endpoint: Change in pain intensity on VAS over first 30 minutes. Planned start Jun 2026; status: authorised.
02
Drugs
methoxyflurane
03
Conditions
pain
Beyond the preview
Go deeper on 2025-525001-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-525001-21-00.